Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19)　― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―-Reference-Cited by-同舟云学术

Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19)　― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

Published:2021-02-10 Issue:2 Volume:3 Page:100-104
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Mizuno Atsushi¹²³⁴,Matsumoto Chisa⁵⁴,Kishi Takuya⁶⁴,Ishida Mari⁷⁴,Sanada Shoji⁸⁴,Fukuda Memori⁹⁴,Komuro Issei¹⁰¹¹,Hirata Kenichi¹²¹¹,Node Koichi¹³⁴¹¹

Affiliation:

1. Department of Cardiovascular Medicine, St. Luke’s International Hospital

2. Penn Medicine Nudge Unit, University of Pennsylvania

3. Leonard Davis Institute for Health Economics, University of Pennsylvania

4. Information and Communication Committee, the Japanese Circulation Society

5. Department of Cardiology, Center for Health Surveillance & Preventive Medicine, Tokyo Medical University

6. Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare

7. Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University

8. Center for Clinical Research and Innovation, Osaka City University Hospital

9. Department of Cardiology, Keio University School of Medicine

10. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

11. Executive Committee, the Japanese Circulation Society

12. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

13. Department of Cardiovascular Medicine, Saga University

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/2/3_CR-21-0003/_pdf

Reference14 articles.

1. 1. Omer SB, Malani P, del Rio C. The COVID-19 pandemic in the US: A clinical update. JAMA 2020; 323: 1767–1768.

2. 2. Mossa-Basha M, Medverd J, Linnau K, Lynch JB, Wener MH, Kicska G, et al. Policies and guidelines for COVID-19 preparedness: Experiences from the University of Washington. Radiology 2020; 296: E26–E31.

3. 3. Shih CK, Chan JC, Lai JS. Maintenance of ophthalmic specialist out-patient service during the COVID-19 outbreak: The University of Hong Kong experience. Eye (Lond) 2020; 34: 1241–1242.

4. 4. Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: Endorsed by the American College of Cardiology. J Am Coll Cardiol 2020; 75: 3078–3084.

5. 5. Mullen B. ACC Clinical Bulletin COVID-19: Clinical guidance for the CV Care Team; 2020. https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/02/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf?fbclid=IwAR1ABbqUAoYdoFkr-kKJV9ii9IyyfN26eDOq7i2dAyrb6qOpkrHtL74MoEw (accessed January 12, 2021).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of acute ischemic stroke in Hiroshima city during the COVID-19 era from HARP study;Japanese Journal of Stroke;2024

2. Second Nationwide Survey of Japanese Cardiac Rehabilitation Training Facilities During the Coronavirus Disease 2019 (COVID-19) Outbreak;Circulation Reports;2022-10-07

3. Hospitalizations for Cardiovascular Diseases During the Early Stage of the COVID-19 Pandemic in Japan;Circulation Reports;2022-08-10

4. Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan;Global Health & Medicine;2022-04-30

5. Current Status and Issues of Remote Cardiac Rehabilitation Therapy;The Japanese Journal of Rehabilitation Medicine;2022-04-18